Formycon And MS Pharma Add Ustekinumab To MENA Alliance

Follows Earlier Biosimilars Deals On Ranibizumab And Aflibercept

 
• By Dave Wallace
  
The partners have racked up a third collaboration (Shutterstock)

More from Deals

More from Products